Development of Tamoxifen-Stimulated Growth of MCF-7 Tumors in Athymic Mice after Long-Term Antiestrogen Administration

Cancer Research

Volumn 48, Issue 18, 1988, Pages 5183-5187

  Gottardis, Marco M ^a   Jordan, V Craig ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; TAMOXIFEN;

ANIMAL EXPERIMENT; BREAST CARCINOMA; CELL STRAIN MCF 7; FEMALE; GROWTH STIMULATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; FEMALE; HUMAN; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, ESTROGEN; SUPPORT, U.S. GOV'T, P.H.S.; TAMOXIFEN; TIME FACTORS;

EID: 0023760993     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Furr, B. J. A., and Jordan, V. C. The pharmacology and clinical uses of tamoxifen. Pharmacol. Ther., 25: 127-205, 1984.
2. Sutherland, R. L., Green, M. D., Hall, R. E., Reddel, R. R., and Taylor, I. W. Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the G0/G, phase of the cell. Eur. J. Cancer Clin. Oncol., 19: 615-621, 1983.
3. Osborne, C. K., Boldt, D. H., Clark, G. M., and Trent, J. M. Effects of tamoxifen in human breast cancer cell cycle kinetics: Accumulation of cells in early G, phase. Cancer Res., 43: 3583-3585, 1983.
4. Jordan, V. C., Allen, K. E., and Dix, C. J. Pharmacology of tamoxifen in laboratory animals. Cancer Treat. Rep., 64: 745-759, 1980.
5. Gottardis, M. M., and Jordan, V. C. The antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res., 47: 4020-4027, 1987.
6. Osborne, C. K., Hobbs, K., and Clark, G. M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res., 45: 584-590, 1985.
7. Gottardis, M. M., Robinson, S. P., and Jordan, V. C. Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: A model to study the tumoristatic action of taxoxifen. J. Steroid Biochem., 30: 311 -314, 1988.
8. Tormey, D. C., and Jordan, V. C. Long-term tamoxifen adjuvant therapy in node-positive breast cancer: A metabolic and pilot clinical study. Breast Cancer Res. Treat., 4: 297-302, 1984.
9. Baum, M., and other members of the “Nolvadex” Adjuvant Trial Organization. Controlled trial of tamoxifen as an adjuvant agent in the management of early breast cancer cycle. Lancet, 1: 257-261, 1983.
10. Fisher, B., and other NASBP Investigators. Prolonging tamoxifen for primary breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project Clinical Trial. Ann. Intern. Med., 106: 649-654, 1987.
11. Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC). Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial. Lancet, 2: 171-175, 1987.
12. Shafie, S. M., and Grantham, F. H. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymicmice. J. Nail. Cancer Inst., 67: 51-56, 1981.
13. Brunner, N., Spang-Thomsen, M., Vindelev, L., Wolff, J., and Engleholm, S. A. Effect of tamoxifen on the receptor-positive T61 and the receptor negative T60 human breast carcinomas grown in nude mice. Eur. J. Cancer Clin. Oncol., 21: 1349-1354, 1985.
14. Osborne, C. K., Coronado, E. B., and Robinson, J. P. Human breast cancer in the athymic nude mouse: Cytostatic effects of long-term antiestrogen therapy. Eur. J. Cancer Clin. Oncol., 23: 1189-1196, 1987.
15. Jordan, V. C., Fritz, N. F., Gottardis, M. M., Mirecki, D. M., Ravdin, P. M., and Welshons, W. V. Laboratory and clinical research on the hormone dependence of breast cancer: Current studies and future prospects. In: V. C. Jordan (ed.), Estrogen/Antiestrogen Action and Breast Cancer Therapy, pp. 501-522. Madison, WI: University of Wisconsin Press, 1986.
16. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
17. Clarke, C. L., and Satyaswaroop, P. G. Photo affinity labeling of the progesterone receptor from human endometrial carcinoma. Cancer Res., 45: 5417-5420, 1985.
18. Unioni. J., Mouridsen, H. T., and Soerensen, H. M. Tamoxifen in advanced endometrial carcinoma. Cancer Chemother. Pharmacol., 4: 213, 1980.
19. Swenerton, K. D. Treatment of advanced endometrial adenocarcinoma with tamoxifen. Cancer Treat. Rep., 64: 805-811, 1980.
20. Bonte, J., Ide, P., Billet, G., and Wynarts, P. Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma. Gynecol. Oncol., 11: 140-161, 1981.
21. Berthois, Y., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA, 83: 2496-2500, 1986.
22. Tormey, D. C., Simon, R. M., Lippman, M. E., Bull, J. M., and Myers, C. E. Evaluation of tamoxifen dose in advanced breast cancer: A progress report. Cancer Treat. Rep., 60: 1451-1459, 1976.
23. Mclntosh, I. H., and Thynne, G. S. Tumor stimulation by antiestrogens. Mr. J. Surg. 64: 900-901, 1977.
24. Plotkin, D., Lechner, J. J., Jung, W. E., and Rosen, P. J. Tamoxifen flare in advanced breast cancer. JAMA, 240: 2644-2646, 1978.
25. Legault-Poisson, S., Jolivet, J., Poisson, R., Peretta-Piccoli, M., and Band, P. R. Tamoxifen-induced tumor stimulation and withdrawal response. Cancer Treat. Rep., 63: 1839-1841, 1979.
26. Smith, I. E., Harris, A. L., Morgan, M., Ford, H. T., Gazet, J-C, Harmer, C. L., White, H., Parsons, C. A., Villardo, A., Walsh, G., and McKinna, J. A. Tamoxifen versus aminoglutethimide in advanced breast carcinoma: A randomized cross-over trial. Br. Med. J., 283: 1432-1434, 1981.
27. Ross, M. B., Buzdar, A. U., and Blumenschein, G. R. Treatment of advanced breast cancer with megesterol acetate after therapy with tamoxifen. Cancer, (Phila.), 49: 413-417, 1982.
28. Ingle, J. N., Krook, J. E., Green, S. J., Kubista, T. P., Everson, L. K., Ahmann, D. L., Chang, M. N., Bisel, H. F., Windschitl, H. E., Twito, D. L., and Pfeifle, D. M. Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer. J. Clin. Oncol., 4: 178-185, 1986.
29. Seibert, K., Shafie, S. M., Triche, T. J., Whang-Peng, J. J., O'Brien, S. J., Toney, J. H., Huff, K. K., and Lippman, M. E. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res., 43: 2223-2239, 1983.
30. Screpanti, L, Santoni, A., Gulino, A., Herberman, R. B., and Frati, L. Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes. Cell. Imimmol., 106: 191-202, 1987.
31. Jordan, V. C., and Robinson, S. P. Species-specific pharmacology of antiestrogens: Role of metabolism. Fed. Proc., 46: 1870-1874, 1987.
32. Gottardis, M. M., Robinson, S. P., Satyaswaroop, P. G., and Jordan, V. C. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res., 48: 812-814, 1988.